Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita

NCT00936533 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa Simplex

Interventions

DRUG: Dysport® (Botulinumtoxin A (Btx A))
DRUG: Placebo

Sponsor

Uppsala University